Top Story

Hypertension self-management program linked to lower BP at 12 months

August 26, 2014

A self-monitoring, self-titration program for high-risk patients with hypertension was associated with reduced BP at 12 months.

For the TASMIN-SR trial, Richard J. McManus, FRCGP, and colleagues studied 552 patients aged 35 years and older with baseline systolic BP ≥130 mm Hg/diastolic BP ≥80 mm Hg who had a history of stroke, CHD, diabetes or chronic kidney disease.

USPSTF recommends behavioral counseling for obese, overweight people at risk for CVD

August 25, 2014
The United States Preventive Services Task Force recommended that adults who are overweight or obese and have at least one risk factor for CVD be offered or referred to…

FEMA grant awarded to reduce obesity, CVD among volunteer firefighters

August 23, 2014
The Federal Emergency Management Agency has awarded the University of Texas Health Science Center a $1.5 million grant to examine the effectiveness of an online program…
figure In the Journals

IGF-I levels, low and high, linked with CV disease in older men

August 22, 2014
Serum insulin-like growth factor-I levels measuring either low or high could increase the risk for cardiovascular disease in older men, according to research published…
CME

Obesity Consults: Volume 1, Number 4

This activity is supported by an educational grant from Vivus.

12/1/2013
Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
CME

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

7/23/2014
Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »

Filter By:

In the Journals

Hypertension self-management program linked to lower BP at 12 months

August 26, 2014
A self-monitoring, self-titration program for high-risk patients with hypertension was associated with reduced BP at 12 months.For the TASMIN-SR…

USPSTF recommends behavioral counseling for obese, overweight people at risk for CVD

August 25, 2014
The United States Preventive Services Task Force recommended that adults who are overweight or obese and have at least one risk factor for CVD be…

FEMA grant awarded to reduce obesity, CVD among volunteer firefighters

August 23, 2014
The Federal Emergency Management Agency has awarded the University of Texas Health Science Center a $1.5 million grant to examine the effectiveness…
figure In the Journals

IGF-I levels, low and high, linked with CV disease in older men

August 22, 2014
Serum insulin-like growth factor-I levels measuring either low or high could increase the risk for cardiovascular disease in older men, according to…
figure In the Journals

Fenofibrate cut adverse CV outcomes in women with diabetes by one-third

August 18, 2014
Women with type 2 diabetes who are at risk for heart disease had a 30% reduction in adverse cardiovascular outcomes with the cholesterol-lowering…
In the Journals

Instant noodles intake linked with metabolic syndrome in Korean women

August 14, 2014
Eating instant noodles as part of a regular diet could increase the likelihood for metabolic syndrome, more so in women than men, according to…
figure FDA News

FDA opens dialogue on interim results of CV safety in diabetes drug trials

August 12, 2014
The FDA has launched a dialogue on how to handle confidentiality of the interim results for cardiovascular outcomes in diabetes treatment trials…
In the Journals

Lifestyle risk factors for CVD rise along with urbanization

August 4, 2014
As urban living increases around the globe, so does the prevalence of lifestyle risk factors for cardiometabolic diseases, according to research…
Industry News

Sanofi, Regeneron to submit PCSK9 application for priority review

August 2, 2014
Regeneron Pharmaceuticals, Inc. and Sanofi announced that they plan to use an FDA rare pediatric disease priority review voucher to submit a…
FDA approvals

FDA approves Lumizyme to treat infantile-onset Pompe disease

August 1, 2014
Alglucosidase alfa was today deemed safe by the FDA for treating patients younger than 8 years old who have Pompe disease and its Risk Evaluation and…
More Headlines »